Cardiovascular mortality in hemodialysis patients: Clinical and epidemiological analysis

Journal of Medical Biochemistry

Volumn 30, Issue 4, 2011, Pages 302-308

  Petrović, Dejan ^a   Obrenović, Radmila ^b   Trbojević Stanković, Jasna ^c   Majkić Singh, Nada ^b   Stojimirović, Biljana ^d  

^a CLINICAL CENTER KRAGUJEVAC   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c Clinical Center Dr Dragisa Misovic   (Serbia)

^d CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

C reactive protein; cardiovascular mortality; hemodialysis; risk factors; troponin T

Indexed keywords

C REACTIVE PROTEIN; HOMOCYSTEINE; TROPONIN; TROPONIN I; TROPONIN T;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; ECHOCARDIOGRAPHY; EPIDEMIC; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODIALYSIS PATIENT; HUMAN; ISCHEMIC HEART DISEASE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; RISK FACTOR;

EID: 80051482103     PISSN: 14528258     EISSN: 14528266     Source Type: Journal    
DOI: 10.2478/v10011-011-0027-1     Document Type: Article

References (36)

1. Parfrey PS. Cardiac disease in dialysis patients: Diag-nosis, burden of disease, prognosis, risk factors and ma nagement. Nephrol Dial Transplant 2000; 15 (Suppl 5): 58 68.
2. Zoccali C. Traditional and emerging cardiovascular and renal risk factors: An epidemiologic perspective. Kidney Int 2006; 70 (1): 26-33. (Pubitemid 44000117)
3. Petrović D, Stojimirović B. Prevalencija faktora rizika za razvoj kardiovaskularnih komplikacija kod bolesnika na hemodijalizi. U: Kardionefrologija 3. Radenković S, (ed). Niš: GIP PUNTA; 2007: 35-43.
4. Petrović D, Stojimirović B. Protok krvi kroz vaskularni pristup za hemodijalizu-faktor rizika za razvoj kardio-vas kularnih komplikacija kod bolesnika na hemodijalizi. Med Pregl 2007; LX (3-4): 183-6.
5. London GM. Cardiovascular Disease in Chronic Renal Failure: Pathophysiologic Aspects. Semin Dial 2003; 16 (2): 85-94. (Pubitemid 37356820)
6. Herzog CA, Mangrum M, Passman R. Sudden Cardiac Death and Dialysis Patients. Semin Dial 2008; 21 (4): 300-7.
7. Herzog CA. Sudden Cardiac Death and Acute Myocar-dial Infarction in Dialysis Patients: Perspectives of a Cardiologist. Semin Nephrol 2005; 25 (6): 363-6. (Pubitemid 41653427)
8. Herzog CA. Can We Prevent Sudden Cardiac Death in Dialysis PatientšClin J Am Soc Nephrol 2007; 2 (3): 410-12.
9. Petrović D, Tirmenštajn-Janković B, Aivanović M, Ni-ko lić A, Poskurica M, Stojimirović B. Iznenadna sr̃ana smrt kod bolesnika koji se lẽe redovnim hemodija li-zama. Timõ Med Glas 2010; 35 (1-2): 19-26.
10. Parfrey PS, Collingwood P, Foley RN, Bahrle A. Left ventricular disorders detected by M-meode echocar-diography in chronic uraemia. Nephrol Dial Transplant 1996; 11 (7): 1328-31. (Pubitemid 26241425)
11. Middleton RJ, Parfrey PS, Foley RN. Left Ventricular Hypertrophy in the Renal Patient. J Am Soc Nephrol 2001; 12 (5): 1079-84. (Pubitemid 32378350)
12. Ie EHY, Zietse R. Evaluation of cardiac function in the dialysis patient-a primer for the non-expert. Nephrol Dial Transplant 2006; 21 (6): 1474-81. (Pubitemid 44063119)
13. Meier P, Vogt P, Blanc E. Ventricular Arrhythmias and Sudden Cardiac Death in End-Stage Renal Disease Patients on Chronic Hemodialysis. Nephron 2001; 87 (3): 199-214. (Pubitemid 32268561)
14. Foley N. Clinical Epidemiology of Cardiac Disease in Dialysis Patients: Left Ventricular Hypertrophy, Ischemic Heart Disease, and Cardiac Failure. Semin Dial 2003; 16 (2): 111-17.
15. Zoccali C, Mallamaci F, Tripepi G. Traditional and emerg-ing cardiovascular risk factors in end-stage renal dis-ease. Kidney Int 2003; 63 (85): 105-10.
16. Petrović D, Stojimirović B. Hipertrofija leve komore kod bolesnika koji se lẽe redovnim hemodijalizama. Med Pregl 2008; LXI (7- 8): 369-74.
17. Herzog CA, Strief JW, Collins A, Gilbertson DT. Causespecific mortality of dialysis patients after coronary revascularisation: Why don't dialysis patients have better survival after coronary interventioňNephrol Dial Trans-plant 2008; 23 (8): 2629-33.
18. Petrović D, Stojimirović B. Cardiovascular morbidity and mortality in hemodialysis patients-epidemiological analysis. Vojnosanit Pregl 2008; 65 (12): 893-900.
19. Dikow R, Adamczak M, Henriquez DE, Ritz E. Stra-tegies to decrease cardiovascular mortality in patients with end-stage renal disease. Kidney Int 2002; 61 (Suppl 80): 5-10.
20. Panteghini M. Role and importance of biochemical markers in clinical cardiology. Eur Heart J 2004; 25 (14): 1187-96. (Pubitemid 38891568)
21. Panteghini M. Biochemical markers of cardiac disease. Jugoslov Med Biohem 2004; 23 (3): 201-11.
22. Jarausch J. Diagnostic and prognostic information pro-vided by a high sensitivity assay for cardiac troponin T. Journal of Medical Biochemistry 2010; 29 (4): 274-81.
23. Derić M, Abarkapa VS. Cardiovascular biomarkers in chronic kidney disease. Journal of Medical Biochem-istry 2010; 29 (4): 298-303.
24. Apple FS, Murakami MAM, Pearce LA, Herzog A. Multi-Biomarker Risk Stratification of N-Terminal Pro-BType Natriuretic Peptide, High-Sensitivity C-Reactive Pro tein, and Cardiac Troponin T and I in End-Stage Renal Disease for All-Cause Death. Clin Chem 2004; 50 (12): 2279-85. (Pubitemid 39552162)
25. Zoccali C, Tripepi G, Mallamaci F. Predictors of Cardio-vascular Death in ESRD. Semin Nephrol 2005; 25 (6): 358-62.
26. Mallamaci F, Tripepi G, Cutrupi S, Malatino LS, Zoccali C. Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardio-pathy in patients with ESRD. Kidney Int 2005; 67(6): 2330-7. (Pubitemid 41623394)
27. Dierkes J, Domröse U, Westphal S, Ambrosch A, Bos-selmann H P, Neumann KH, et al. Cardiac Troponin T Predicts Mortality in Patients With End-Stage Renal Disease. Circulation 2000; 102 (16): 1964-75.
28. Ooi DS, Zimmerman D, Graham J, et al. Cardiac Tro-po nin T Predicts Long-term Outcomes in Hemodialysis Patients. Clin Chem 2001; 47 (3): 412-17. (Pubitemid 32222453)
29. Ishii J, Nomura M, Okuma T, et al. Risk stratification using serum concentrations of cardiac troponin T in patients with end-stage renal disease on chronic main-tenance dialysis. Clin Chim Acta 2001; 312(1): 69-79. (Pubitemid 32913582)
30. De Filippi C, Wasserman S, Rosanio S, Tiblier E, Sper-ger H, Tocchi M, Christenson R, et al. Cardiac Troponin T and C-Reactive Protein for Predicting Prognosis, Co r-o nary Atherosclerosis, and Cardiomyopathy in Patients Undergoing Long-term Hemodialysis. JAMA 2003; 290 (3): 353-9. (Pubitemid 37430521)
31. Petrović D, Obrenović R, Stojimirović B. Cardiac tro po-nins and left ventricular hypertrophy in hemodialysis patients. Clin Lab 2008; 54 (5-6): 145-52.
32. Petrović D, Jagić N, Miloradović V, Stojimirović B. Cli ni-cal importance of biochemical markers of cardiac da m-age in hemodialysis patients. Ser J Exp Clin Res 2008; 9 (1): 5-8.
33. Johnson DW, Craven AM, Isbel NM. Modification of car-diovascular risk in hemodialysis patients: An evi de ncebased review. Haemodialysis Int 2007; 11 (1): 1-14. (Pubitemid 46128673)
34. Petrović D, Stojimirović B. Cardiac troponins: Outcome predictors in hemodialysis patients. J Artif Organs 2009; 12 (4): 258-63.
35. Saravanan P, Davidson NC. Risk Assessment for Sudden Cardiac Death in Dialysis Patients. Circ Arrhythm Ele ctro physiol 2010; 3 (5): 553-9.
36. Kanabay M, Afsar B, Goldsmith D, Covic A. Sudden Death in Hemodialysis: An Update. Blood Purif 2010; 30 (2): 135-45.